Call Us Free: (800) 394-2767

Archive for the Insurance News Category

Why this Peninsula drug maker's stock soared 40% higher today

Why this Peninsula drug maker's stock soared 40% higher today

Shares of Myovant Sciences Ltd. soared as much as 55% Monday after the company this weekend unloaded fresh data around a drug for prostate cancer and said this morning that it is asking regulators to approve the same drug’s use to treat women with uterine fibroids. The […]

Read more

An estimated 20,000 Oregonians have been infected with Covid-19

An estimated 20,000 Oregonians have been infected with Covid-19

The Institute for Disease Modeling said the trend of lower infections could change as counties begin reopening. Source link

Read more

SSM Health names medical chief for SLU Hospital

SSM Health names medical chief for SLU Hospital

Dr. Matthew Broom was named chief medical officer and vice president of medical affairs for SSM Health Saint Louis University Hospital, effective Monday. Broom had held the hospital’s top medical post on an interim basis since November, while also serving full time as chief medical officer and […]

Read more

How Covid-19 changed the way Jumpstart Foundry chose its 2020 portfolio

How Covid-19 changed the way Jumpstart Foundry chose its 2020 portfolio

“When Covid hit it was a matter of: What stance do we want to take in this? Do we want to be the ones that hunker down and conserve cash?” Jumpstart Foundry Managing Director Eller Mallchok said. Source link

Read more

North Carolina tech company partners with Amazon to support thousands during Covid-19

North Carolina tech company partners with Amazon to support thousands during Covid-19

A Triangle tech company already seeing a massive spike in demand during the Covid-19 pandemic has a new initiative alongside a global tech giant to roll out its product to thousands of more seniors. Last week, Raleigh-based K4Connect, announced a new initiative supported by Amazon (NASDAQ: AMZN) […]

Read more

Malvern biopharm firm signs $50M loan deal to support the launch of new drug

Malvern biopharm firm signs $50M loan deal to support the launch of new drug

The company’s first FDA-approved product launch was delayed by the coronavirus outbreak. Source link

Read more

Dental school prepares for thousands of patients

Dental school prepares for thousands of patients

The University at Buffalo School of Dental Medicine is preparing for a surge of patients, but won’t reopen right away. Source link

Read more

Gilead's latest Covid study finds mixed results for 'moderate' patients — and that may be good

Gilead's latest Covid study finds mixed results for 'moderate' patients — and that may be good

The marquee drug in the fight against Covid-19 helped most “moderate” Covid pneumonia patients improve after five days but those treated over 10 days did not see an improvement that was statistically significant. Covid pneumonia patients who didn’t require ventilation and were given remdesivir from based Gilead […]

Read more

Why four years is important for BioMarin, hemophilia patients

Why four years is important for BioMarin, hemophilia patients

An experimental gene therapy for hemophilia A from BioMarin Pharmaceutical Inc. — promising a one-shot fix for the genetic cause of the bleeding disorder — continues to hold patients’ bleeds to less than one a year after four years. The results of the ongoing study are important as […]

Read more

Vaccine makers cash in on Covid wave to raise millions

Vaccine makers cash in on Covid wave to raise millions

Going up against the big kids of the vaccine-development world, small Bay Area companies and others are seeing their stock prices rise. Source link

Read more